{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:26:25Z","timestamp":1761863185284},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,4,15]]},"DOI":"10.1097\/qai.0b013e31827e8f98","type":"journal-article","created":{"date-parts":[[2012,11,29]],"date-time":"2012-11-29T09:06:59Z","timestamp":1354180019000},"page":"534-539","source":"Crossref","is-referenced-by-count":34,"title":["Efavirenz, in Contrast to Nevirapine, is Associated With Unfavorable Progesterone and Antiretroviral Levels When Coadministered With Combined Oral Contraceptives"],"prefix":"10.1097","volume":"62","author":[{"given":"Nadia Kancheva","family":"Landolt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nittaya","family":"Phanuphak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sasiwimol","family":"Ubolyam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suteeraporn","family":"Pinyakorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosalin","family":"Kriengsinyot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennisa","family":"Ahluwalia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parawee","family":"Thongpaeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meena","family":"Gorowara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narukjaporn","family":"Thammajaruk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surasith","family":"Chaithongwongwatthana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joep M. A.","family":"Lange","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jintanat","family":"Ananworanich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-9-20210131","first-page":"449","article-title":"Update to CDCs U.S. Medical Eligibility Criteria for Contraceptive Use, 2010.","volume":"61","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R3-9-20210131","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/00042560-200204150-00007","article-title":". Pharmacokinetic interaction between nevirapine and ethinyl estradiolnorethindrone when administered concurrently to HIV-infected women.","volume":"29","author":"Mildvan","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R4-9-20210131","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1097\/QAI.0b013e31822b8bf8","article-title":". Combined oral contraceptives and antiretroviral PKPD in Malawian women: pharmacokinetics and pharmacodynamics of a combined oral contraceptive and a generic combined formulation antiretroviral in Malawi.","volume":"58","author":"Stuart","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R7-9-20210131","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3851\/IMP1725","article-title":". The effect of efavirenz on the pharmacokinetics of an oral contraceptive containing ethinyl estradiol and norgestimate in healthy HIV-negative women.","volume":"16","author":"Sevinsky","year":"2011","journal-title":"Antivir Ther"},{"key":"R8-9-20210131","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/sj.clpt.6100040","article-title":". Depo-medroxyprogesterone in women on antiretroviral therapy: effective contraception and lack of clinically significant interactions.","volume":"81","author":"Cohn","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"R9-9-20210131","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.fertnstert.2007.07.1348","article-title":". Pharmacokinetic interactions between depot medroxyprogesterone acetate and combination antiretroviral therapy.","volume":"90","author":"Nanda","year":"2008","journal-title":"Fertil Steril"},{"key":"R10-9-20210131","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.contraception.2009.01.009","article-title":". Effect of steady-state etravirine on the pharmacokinetics and pharmacodynamics of ethinylestradiol and norethindrone.","volume":"80","author":"Scholler-Gyure","year":"2009","journal-title":"Contraception"},{"key":"R12-9-20210131","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1592\/phco.29.8.924","article-title":"Lack of effect of tenofovir disoproxilfumarate on pharmacokinetics of hormonal contraceptives.","volume":"29","author":"Kearney","year":"2009","journal-title":"Pharmacotherapy"},{"key":"R14-9-20210131","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/00007691-200306000-00023","article-title":"Simultaneous determination of the HIV drugs indinavir, amprenavir, saquinavir, ritonavir, lopinavir, nelfinavir, the nelfinavir hydroxymetabolite M8, and nevirapine in human plasma by reversed-phase high-performance liquid chromatography.","volume":"25","author":"Droste","year":"2003","journal-title":"Ther Drug Monit"},{"key":"R15-9-20210131","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1067\/mcp.2002.121424","article-title":". The influence of efavirenz on the pharmacokinetics of a twice-daily combination of indinavir and low-dose ritonavir in healthy volunteers.","volume":"71","author":"Aarnoutse","year":"2002","journal-title":"Clin Pharmacol Ther"},{"key":"R16-9-20210131","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/FTD.0b013e31820fa528","article-title":". The international interlaboratory quality control program for measurement of antiretroviral drugs in plasma: a global proficiency testing program.","volume":"33","author":"Burger","year":"2011","journal-title":"Ther Drug Monit"},{"key":"R17-9-20210131","first-page":"177","article-title":". Predicting risk of ovulation in new start oral contraceptive users.","volume":"99","author":"Schwartz","year":"2002","journal-title":"Obstet Gynecol"},{"key":"R18-9-20210131","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1089\/aid.2006.22.232","article-title":". Pharmacokinetic parameters of nevirapine and efavirenz in relation to antiretroviral efficacy.","volume":"22","author":"Leth","year":"2006","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R19-9-20210131","first-page":"31","article-title":". Midluteal serum progesterone levels and pregnancy following ovulation induction with human follicle-stimulating hormone: results of a combined-data analysis.","volume":"56","author":"Warne","year":"2011","journal-title":"J Reprod Med"},{"key":"R22-9-20210131","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1097\/QAD.0b013e32833a2a14","article-title":". Safety of efavirenz in first-trimester of pregnancy: a systematic review and meta-analysis of outcomes from observational cohorts.","volume":"24","author":"Ford","year":"2010","journal-title":"AIDS"},{"key":"R23-9-20210131","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.contraception.2011.09.005","article-title":". Contraceptive failure of etonogestrel implant in patients treated with antiretrovirals including efavirenz.","volume":"85","author":"Leticee","year":"2012","journal-title":"Contraception"},{"key":"R24-9-20210131","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1783\/147118907782101724","article-title":"Early contraceptive failure of Implanon in an HIV-seropositive patient on triple antiretroviral therapy with zidovudine, lamivudine and efavirenz.","volume":"33","author":"Matiluko","year":"2007","journal-title":"J Fam Plann Reprod Health Care"},{"key":"R25-9-20210131","first-page":"244","article-title":". Plasma nevirapine levels and 24-week efficacy of a fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-VIR) among Thai HIV-infected patients.","volume":"90","author":"Manosuthi","year":"2007","journal-title":"J Med Assoc Thai"},{"key":"R26-9-20210131","first-page":"309","article-title":". Efavirenz plasma levels for the prediction of treatment failure in heavily pretreated HIV-1 infected patients.","volume":"7","author":"Langmann","year":"2002","journal-title":"Eur J Med Res"},{"key":"R31-9-20210131","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1124\/dmd.104.000182","article-title":". The involvement of CYP3A4 and CYP2C9 in the metabolism of 17 alpha-ethinylestradiol.","volume":"32","author":"Wang","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"R32-9-20210131","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/FPC.0b013e32834dd82e","article-title":". Association of ABCC10 polymorphisms with nevirapine plasma concentrations in the German Competence Network for HIVAIDS.","volume":"22","author":"Liptrott","year":"2012","journal-title":"Pharmacogenet Genomics"},{"key":"R33-9-20210131","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1254\/jphs.08209FP","article-title":". Induction of multiple drug transporters by efavirenz.","volume":"109","author":"Weiss","year":"2009","journal-title":"J Pharmacol Sci"},{"key":"R34-9-20210131","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/FTD.0b013e31824868f3","article-title":". Associations between ABCB1, CYP2A6, CYP2B6, CYP2D6, and CYP3A5 alleles in relation to efavirenz and nevirapine pharmacokinetics in HIV-infected individuals.","volume":"34","author":"Heil","year":"2012","journal-title":"Ther Drug Monit"},{"key":"R35-9-20210131","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1530\/acta.0.1110553","article-title":"Pulsatile secretion of progesterone from the human corpus luteum: poor correlation with bioactive LH pulses.","volume":"111","author":"Beitins","year":"1986","journal-title":"Acta Endocrinol (Copenh)"},{"key":"R36-9-20210131","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1365-2265.1990.tb03745.x","article-title":". Secretory dynamics of oestradiol (E2) and progesterone (P4) during periods of relative pituitary LH quiescence in the midluteal phase of the menstrual cycle.","volume":"32","author":"Rossmanith","year":"1990","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R37-9-20210131","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.maturitas.2004.01.001","article-title":"Pharmacological profile of progestins.","volume":"47","author":"Sitruk-Ware","year":"2004","journal-title":"Maturitas"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00126334-201304150-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:54:31Z","timestamp":1618037671000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00126334-201304150-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,15]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e31827e8f98","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4,15]]}}}